Interventional Oncology Ablation Market, By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation ), By Indication (Liver Cancer, Kidney Cancer, Lung Cancer, Others), By End User (Hospitals & Clinics,

Interventional Oncology Ablation Market, By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation ), By Indication (Liver Cancer, Kidney Cancer, Lung Cancer, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Interventional oncology ablation involves minimally invasive, image-guided procedures to deliver localized cancer treatment. There are two main types of ablation techniques: thermal and non-thermal. Thermal techniques like radiofrequency ablation (RFA), microwave ablation, and cryoablation use heat or cold energy to destroy cancer cells. RFA uses high-frequency electrical currents to generate heat and induce tumor coagulation necrosis. It is widely used for treating liver, kidney, lung, and bone tumors. Microwave ablation applies electromagnetic microwaves to agitate water molecules and produce frictional heat to ablate tissue. Cryoablation freezes and destroys diseased tissue by applying extremely cold temperatures through cooled probes. Non-thermal techniques include irreversible electroporation, which applies short electric pulses to form nanopores in cell membranes, leading to apoptosis. Ablation therapies are minimally invasive, allow for quicker recovery, have fewer side effects, and can be performed repeatedly. They are ideal for inoperable cancers, patients unfit for surgery, and metastatic or recurrent tumors. Ongoing advances focus on improving ablation zone size and precision. Emerging techniques like high-intensity focused ultrasound ablation, photodynamic therapy, and nanoparticle-mediated ablation also show promise in expanding interventional oncology treatment.

Market Dynamics

The constantly increasing number of cancer patients in the market is expected to drive growth of the global interventional oncology ablation market over the forecast period. For instance, in February 2023, according to data published by the American Society of Clinical Oncology (ASCO), there were more than 3.8 million women living with or beyond breast cancer in the U.S. In 2023, an estimated 297,790 women in the U. S. will be diagnosed with invasive breast cancer, 55,720 women will be diagnosed with non-invasive (in situ) breast cancer, and 43,700 deaths (43,170 women and 530 men) from breast cancer will occur in the U.S.

Key features of the study:

• This report provides an in-depth analysis of the global interventional oncology ablation market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global interventional oncology ablation market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc., STARmed Co., and Biomedical Srl.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global interventional oncology ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interventional oncology ablation market

Interventional Oncology Ablation Market Detailed Segmentation:

• By Technology:
• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Irreversible Electroporation Ablation
• By Indication:
• Liver Cancer
• Kidney Cancer
• Lung Cancer
• Others
• By End User:
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others
• By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic Plc
• Varian Medical Systems, Inc.
• EDAP TMS S.A.
• AngioDynamics
• CASCINATION AG
• Merit Medical Systems, Inc.
• STARmed Co.
• Biomedical Srl.